- Home
- ARGX vs FICO Comparison
ARGX vs FICO Comparison
Compare ARGX & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- FICO
- Stock Information
- Founded
- ARGX 2008
- FICO 1956
- Country
- ARGX Netherlands
- FICO United States
- Employees
- ARGX N/A
- FICO N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- FICO Business Services
- Sector
- ARGX Health Care
- FICO Consumer Discretionary
- Exchange
- ARGX Nasdaq
- FICO Nasdaq
- Market Cap
- ARGX 40.4B
- FICO 48.4B
- IPO Year
- ARGX 2017
- FICO 1987
- Fundamental
- Price
- ARGX $549.65
- FICO $2,089.48
- Analyst Decision
- ARGX Strong Buy
- FICO Buy
- Analyst Count
- ARGX 20
- FICO 12
- Target Price
- ARGX $698.22
- FICO $2,236.75
- AVG Volume (30 Days)
- ARGX 423.4K
- FICO 177.1K
- Earning Date
- ARGX 05-08-2025
- FICO 04-29-2025
- Dividend Yield
- ARGX N/A
- FICO N/A
- EPS Growth
- ARGX N/A
- FICO 21.78
- EPS
- ARGX 15.94
- FICO 23.21
- Revenue
- ARGX $2,643,062,000.00
- FICO $1,840,361,000.00
- Revenue This Year
- ARGX $60.97
- FICO $17.79
- Revenue Next Year
- ARGX $31.50
- FICO $15.57
- P/E Ratio
- ARGX $32.07
- FICO $89.95
- Revenue Growth
- ARGX 82.13
- FICO 14.71
- 52 Week Low
- ARGX $352.77
- FICO $1,240.31
- 52 Week High
- ARGX $678.21
- FICO $2,402.52
- Technical
- Relative Strength Index (RSI)
- ARGX 36.21
- FICO 65.74
- Support Level
- ARGX $529.11
- FICO $2,035.94
- Resistance Level
- ARGX $658.93
- FICO $2,112.05
- Average True Range (ATR)
- ARGX 17.55
- FICO 56.11
- MACD
- ARGX -6.04
- FICO 14.31
- Stochastic Oscillator
- ARGX 15.82
- FICO 85.76
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
About FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.